Cardiol Therapeutics (CRDL) Receivables: 2021-2022
Historic Receivables for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to -$34,464.
- Cardiol Therapeutics' Receivables rose 73.78% to -$34,464 in Q3 2022 from the same period last year, while for Sep 2022 it was $229,004, marking a year-over-year change of. This contributed to the annual value of $324,869 for FY2021, which is N/A change from last year.
- Per Cardiol Therapeutics' latest filing, its Receivables stood at -$34,464 for Q3 2022, which was down 1,353.99% from $2,748 recorded in Q2 2022.
- Cardiol Therapeutics' 5-year Receivables high stood at $322,989 for Q4 2021, and its period low was -$377,689 during Q2 2021.
- Its 2-year average for Receivables is -$50,897, with a median of -$62,269 in 2022.
- Data for Cardiol Therapeutics' Receivables shows a peak YoY surged of 100.73% (in 2022) over the last 5 years.
- Quarterly analysis of 2 years shows Cardiol Therapeutics' Receivables stood at $322,989 in 2021, then surged by 73.78% to -$34,464 in 2022.
- Its last three reported values are -$34,464 in Q3 2022, $2,748 for Q2 2022, and -$62,269 during Q1 2022.